Novel CDK6 inhibitor

Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)

Novel EGFR triple mutant T790M/C797S allosteric inhibitor

Novel GDNF Family Receptor Agonist

Potent Ebolavirus (EBOV) Inhibitor

Novel Nef Protein Inhibitor; Anti-HIV

Novel blocker of AKT1-FAK interaction, reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylation

Novel Zika virus RNA polymerase inhibitor

Novel CtpF inhibitor, inhibiting Ca -dependent ATPase activity in Mtb membrane vesicles

Novel gp120 of HIV-1 Antagonist

Novel potent and specific inhibitor of the UNC119-Src interaction, binding to UNC119 in cells, and inducing redistribution of Src to endomembranes and reduction of activating Src autophosphorylation on Y419

Novel ASCT2 inhibitor

Cell-permeable fluorometric zinc sensor

Non-competitive AMPA receptor antagonist

Type III progesterone receptor antagonist with enhanced antiproliferative properties

Novel oral multitarget tumour growth inhibitor

Novel potent inhibitor of factor Xa (FXa)

Novel dual mordulator of nNOS-PSD-95 interaction and GABA A receptor

Novel potent and selective BRD4 bromodomain 1 (BD1) inhibitor

Novel potent and selective BRD4 bromodomain 1 (BD1) inhibitor

Novel β-catenin/B-cell lymphoma 9 (BCL9) inhibitor, disrupting the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.96 μM and without affecting the β-catenin/E-cadherin interaction in living cells, displaying good selectivity for β-catenin/

Novel potent and highly selective inhibitor of wild-type and mutant versions of EZH2